(WTW) Willis Towers Watson - Ratings and Ratios

Exchange: NASDAQ • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: IE00BDB6Q211

WTW: Insurance, Consulting, Broking, Services, Solutions, Software

Willis Towers Watson PLC, trading under the ticker WTW on NASDAQ, stands as a global powerhouse in advisory, broking, and solutions. With roots tracing back to 1828, this firm has evolved into a key player in the insurance and consulting sectors. Its dual segments—Health, Wealth & Career and Risk & Broking—underscore its comprehensive approach to serving clients across various industries.

The Health, Wealth & Career segment offers a suite of services designed to optimize employee benefits and retirement plans. From strategy consulting to plan management, WTW helps organizations enhance their health and wellbeing programs, including medical, dental, and life insurance. Their expertise extends to retirement consulting, ensuring pension and savings plans are both sustainable and aligned with organizational goals.

The Risk & Broking segment is where WTWs insurance brokerage and risk management capabilities shine. They cater to diverse sectors such as property and casualty, aerospace, and natural resources, providing tailored solutions to mitigate risks. Their services encompass everything from risk assessment to crisis management, underpinned by data-driven insights and advanced analytics.

WTWs commitment to innovation is evident in their integration of technology. They leverage software solutions to enhance risk and capital management, offering tools for financial modeling and regulatory reporting. This blend of human expertise and technological prowess positions them as a forward-thinking leader in their field.

For investors, WTWs market cap of over $32 billion and a forward P/E of 17.86 indicate a stable yet growth-oriented company. Their price-to-sales ratio of 3.33 suggests a premium valuation, reflecting their strong market position and diverse service offerings. This makes WTW an attractive consideration for those seeking exposure to the insurance and consulting sectors with a global reach and a history of resilience.

Additional Sources for WTW Stock

WTW Stock Overview

Market Cap in USD 32,987m
Sector Financial Services
Industry Insurance Brokers
GiC Sub-Industry Multi-line Insurance
IPO / Inception 2016-01-05

WTW Stock Ratings

Growth 5y 74.2%
Fundamental 25.3%
Dividend 57.2%
Rel. Strength Industry 3.11
Analysts 3.95/5
Fair Price Momentum 353.57 USD
Fair Price DCF 350.46 USD

WTW Dividends

Dividend Yield 12m 1.14%
Yield on Cost 5y 2.18%
Annual Growth 5y 5.06%
Payout Consistency 97.4%

WTW Growth Ratios

Growth Correlation 3m 84.6%
Growth Correlation 12m 91.3%
Growth Correlation 5y 78.7%
CAGR 5y 14.21%
CAGR/Max DD 5y 0.50
Sharpe Ratio 12m 0.92
Alpha 16.63
Beta 0.12
Volatility 21.59%
Current Volume 566.6k
Average Volume 20d 563.8k
What is the price of WTW stocks?
As of March 12, 2025, the stock is trading at USD 326.52 with a total of 566,567 shares traded.
Over the past week, the price has changed by -2.46%, over one month by +2.10%, over three months by +8.22% and over the past year by +23.59%.
Is Willis Towers Watson a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Willis Towers Watson is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 25.32 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WTW as of March 2025 is 353.57. This means that WTW is currently overvalued and has a potential downside of 8.28%.
Is WTW a buy, sell or hold?
Willis Towers Watson has received a consensus analysts rating of 3.95. Therefor, it is recommend to buy WTW.
  • Strong Buy: 7
  • Buy: 5
  • Hold: 6
  • Sell: 1
  • Strong Sell: 0
What are the forecast for WTW stock price target?
According to ValueRays Forecast Model, WTW Willis Towers Watson will be worth about 381.9 in March 2026. The stock is currently trading at 326.52. This means that the stock has a potential upside of +16.95%.
Issuer Forecast Upside
Wallstreet Target Price 361.8 10.8%
Analysts Target Price 360.3 10.3%
ValueRay Target Price 381.9 16.9%